secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001193125-23-189147
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q2 GAAP EPS $7.79, adj. EPS $9.04; raises FY2023 guidance
-------------------------------------------------------------------------

- Q2 GAAP net income $7.79/sh, adjusted $9.04/sh; operating revenue $43.4B (+12.7% YoY).
- Medical enrollment 48.0M, up 938k YoY; benefit expense ratio improved 70 bps to 86.4%.
- Health Benefits operating gain $2.1B (+21% YoY); Carelon operating gain $632M (+6.8%).
- Raises FY2023 outlook: GAAP EPS >$29.09, adjusted >$32.85.
- Declares Q3 dividend $1.48/sh; repurchased 1.4M shares for $646M in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/0001193125-23-189147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/d528939d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-189147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer